OCGN

Latest SEC Filings & News for OCGN

1 most recent filing and news item mentioning OCGN. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/OCGN/news?limit=20"

Pull OCGN filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

M&AJul 13, 2026Positive

Ocugen Signs License Deal for OCU400 in MENA Region

Ocugen entered a binding term sheet with Roots Pharmaceutical for the exclusive license of OCU400 in the MENA region. The agreement provides up to $255 million in sales milestones and underscores Ocugen's strategic expansion into emerging markets for gene therapies.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.